Finance

Lists
NUZ:ASX
Neurizon Therapeutics Ltd
A$0,063
+12,50%
(+0,0070) 1D
7 Sep., 16:00:00 GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NUZ...
Open
A$0,06
High
A$0,06
Low
A$0,06
Mkt. cap
46,11 m
Avg. vol.
560,86 k
Volume
367,43 k
52-wk high
A$0,16
52-wk low
A$0,05
EPS
-A$0,02
Shares outstanding
784,22 m
No. of employees
52
Open
A$0,06
High
A$0,06
Low
A$0,06
Mkt. cap
46,11 m
Avg. vol.
560,86 k
Volume
367,43 k
52-wk high
A$0,16
52-wk low
A$0,05
EPS
-A$0,02
Shares outstanding
784,22 m
No. of employees
52
News stories
From web sources and news partners
About Neurizon Therapeutics Ltd
CEO-
Employees52
Founded2000
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
2,99 m
2,99 m
5,81 m
5,81 m
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,12 m
4,12 m
6,40 m
6,40 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,40 m
1,40 m
1,73 m
1,73 m
Operating expense
5,70 m
5,70 m
8,17 m
8,17 m
Total operating expenses
5,70 m
5,70 m
8,17 m
8,17 m
Operating income
-2,72 m
-2,72 m
-2,37 m
-2,37 m
Other non operating income
-
-
-
-
EBT including unusual items
-2,77 m
-2,77 m
-2,59 m
-2,59 m
EBT excluding unusual items
-2,77 m
-2,77 m
-2,59 m
-2,59 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,77 m
-2,77 m
-2,59 m
-2,59 m
Net profit margin
-92,70%
-92,70%
-44,66%
-44,66%
Earnings per share
-
-
-
-
Interest and investment income
11,89 k
11,89 k
80,00 k
80,00 k
Interest expense
-63,39 k
-63,39 k
-305,23 k
-305,23 k
Net interest expenses
-51,50 k
-51,50 k
-225,23 k
-225,23 k
Depreciation and amortization charges
359,00
359,00
642,00
642,00
EBITDA
-2,72 m
-2,72 m
-2,37 m
-2,37 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme